The Efficacy and Safety of ARNI on the Outcome of Advanced Lung Cancer With Concurrent Hypertension

NCT07261098 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Advanced Lung Cancer

Interventions

DRUG: ARNI
DRUG: Anti-hypertensive drugs except ARNI

Sponsor

Shanghai Chest Hospital